Faraaz Zafar, MD
Dermatology · West Des Moines, IANPI 1235792912
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations.
Across 182 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$821
- AbbVie$512
- Galderma Laboratories, L.p.$400
- UCB, Inc.$383
- Sun Pharmaceutical Industries Inc.$284
- E.r. Squibb & Sons, L.L.C.$227
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,68893%
- Education$2607%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 34 | $821 |
| AbbVie | 30 | $512 |
| Galderma Laboratories, L.p. | 22 | $400 |
| UCB, Inc. | 14 | $383 |
| Sun Pharmaceutical Industries Inc. | 14 | $284 |
| E.r. Squibb & Sons, L.L.C. | 19 | $227 |
| Lilly USA, LLC | 7 | $191 |
| Organogenesis Inc. | 2 | $170 |
| Sanofi | 6 | $167 |
| Kerecis Limited | 3 | $140 |
| Organon | 7 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| Amgen | 5 | $101 |
| Novartis | 3 | $80 |
| Pfizer | 4 | $78 |
| Boehringer Ingelheim | 2 | $36 |
| Convatec Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Incyte Corporation | 1 | $24 |
| Urgo Medical North America, LLC | 1 | $23 |
| LNHC, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,948 in reported general payments places this provider in the 80th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 20 | $2,191 |
| Clobetasol Propionate | 49 | $2,060 |
| Fluorouracil | 11 | $958 |
| Metronidazole | 13 | $754 |
| Betamethasone Dipropionate | 14 | $614 |
| Ketoconazole | 40 | $568 |
| Triamcinolone Acetonide | 56 | $467 |
| Clindamycin Phosphate | 16 | $389 |
| Hydrocortisone | 53 | $262 |
| Mupirocin | 42 | $245 |
| MethotrexateMethotrexate Sodium | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other dermatology in West Des Moines
- Roger CeilleyWest Des Moines$82K
- Charles LoveWest Des Moines$5K
- Joshua WilsonWest Des Moines$4K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Ravindrakumar GangadhariahDavenport$20K
- Somaira NowsheenWaukee$15K
- Laura MyersAnkeny$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.